Catalyst Wire Dossier Catalyst Wire Dossier

RENFLEXIS

Infliximab · Organon LLC
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RENFLEXIS, covering 2017-04-21 to 2025-10-28. Get the full timeline:

Most recent: FDA Approved: RENFLEXIS — Supplemental Application (Organon LLC)

See pricing